M

Monsenso A/S
CSE:MONSO

Watchlist Manager
Monsenso A/S
CSE:MONSO
Watchlist
Price: 0.128 DKK -16.34% Market Closed
Market Cap: 8.5m DKK
Section:
 

Relative Value

The Relative Value of one MONSO stock under the Base Case scenario is 0.265 DKK. Compared to the current market price of 0.128 DKK, Monsenso A/S is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MONSO Relative Value
Base Case
0.265 DKK
Undervaluation 52%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
87
vs Industry
54
Median 3Y
1.5
Median 5Y
1.9
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.4
Industry
22.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
28
Median 3Y
-2.5
Median 5Y
-2.8
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-3.8
Industry
21.7
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
57
vs Industry
63
Median 3Y
1
Median 5Y
1.1
Industry
2.2
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
82
vs Industry
66
Median 3Y
1.3
Median 5Y
1.6
Industry
2.5
More Details
1.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.9
vs History
77
vs Industry
68
Median 3Y
3
Median 5Y
3.1
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-5.5
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.9
Industry
16.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
29
Median 3Y
-2.3
Median 5Y
-2.5
Industry
14.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-3.8
Industry
18.6
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
53
vs Industry
69
Median 3Y
0.7
Median 5Y
0.8
Industry
1.8
More Details

Multiples Across Competitors

MONSO Competitors Multiples
Monsenso A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Monsenso A/S
CSE:MONSO
8.5m DKK 0.8 -1.3 -3.4 -1.2
US
Veeva Systems Inc
NYSE:VEEV
36.5B USD 11.8 42.4 32.1 33.5
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
23.2B AUD 105.4 201.6 139.4 139.4
JP
M3 Inc
TSE:2413
1.4T JPY 4.4 31.5 16 19.8
US
Doximity Inc
NYSE:DOCS
8.2B USD 13.2 32.4 28.4 29.7
US
Waystar Holding Corp
NASDAQ:WAY
5.7B USD 5.5 51.6 17.1 26.9
SE
Sectra AB
STO:SECT B
48.8B SEK 22.9 83.3 -116.9 -116.9
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
290.9B INR 10.9 59.9 37.2 43.5
CN
Winning Health Technology Group Co Ltd
SZSE:300253
20.3B CNY 9.4 -65.9 -130.4 -130.4
US
Inspire Medical Systems Inc
NYSE:INSP
2.8B USD 3.2 63 50.3 67.6
P/E Multiple
Earnings Growth PEG
DK
M
Monsenso A/S
CSE:MONSO
Average P/E: 68.7
Negative Multiple: -1.3 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
42.4
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
201.6
32%
6.3
JP
M3 Inc
TSE:2413
31.5
16%
2
US
Doximity Inc
NYSE:DOCS
32.4
18%
1.8
US
W
Waystar Holding Corp
NASDAQ:WAY
51.6
N/A N/A
SE
Sectra AB
STO:SECT B
83.3
28%
3
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
59.9
30%
2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -65.9
92%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
63
13%
4.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
M
Monsenso A/S
CSE:MONSO
Average EV/EBITDA: 42.8
Negative Multiple: -3.4 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
32.1
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
139.4
32%
4.4
JP
M3 Inc
TSE:2413
16
14%
1.1
US
Doximity Inc
NYSE:DOCS
28.4
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
17.1
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -116.9 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.2
24%
1.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -130.4
36%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
50.3
80%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
M
Monsenso A/S
CSE:MONSO
Average EV/EBIT: 50.4
Negative Multiple: -1.2 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.5
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
139.4
31%
4.5
JP
M3 Inc
TSE:2413
19.8
N/A N/A
US
Doximity Inc
NYSE:DOCS
29.7
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
26.9
56%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -116.9 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.5
27%
1.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -130.4
47%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
67.6
34%
2

See Also

Summary
MONSO intrinsic value, competitors valuation, and company profile.
DCF Valuation
MONSO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MONSO stock valuation using valuation multiples.
Wall Street Estimates
MONSO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MONSO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.